To examine the possibility that genetic modification of the ID8 cell line (deleting Trp53, Brca2) might affect tumour progression, we similarly assessed survival of an i.p. model of ID8 ovarian cancer; however the absence of FGL2 did not prolong survival in this model either (Fig. S4B). This evidence concerns the gene BRCA2 and neoplasm.